Table 1 Between-group comparisons of the participants’ demographic and clinical characteristics
Variables | Group | P value | |
|---|---|---|---|
Placebo, Mean ± SD | Intervention, Mean ± SD | ||
Age | 67.94 ± 6.72 | 68.86 ± 6.27 | 0.800a |
Weight (kg) | 75.50 ± 12.44 | 76.02 ± 12.62 | 0.560 a |
Height (cm) | 165.50 ± 6.58 | 165.63 ± 7.04 | 0.640 a |
BMI | 27.54 ± 3.96 | 27.59 ± 3.43 | 0.578 a |
Disease duration, year | 6.91 ± 4.68 | 7.22 ± 4.46 | 0.654 a |
| Â | N (%) | N (%) | Â |
Gender | |||
 Female | 23 (63.9) | 22 (61.1) | 0.99 b |
 Male | 13 (36.1) | 14 (38.9) | |
Education level | |||
 Illiterate | 13 (36.1) | 16 (44.4) | 0.34 c |
 Elementary school | 12 (33.3) | 12 (33.3) | |
 Secondary school | 4 (11.1) | 6 (16.7) | |
 High school and higher | 7 (19.5) | 2 (5.6) | |
Regular physical activity | |||
 Yes | 18 (50.0) | 14 (38.9) | 0.47 b |
 No | 18 (50.0) | 22 (61.1) | |
Analgesic use (during the study) | |||
 Yes | 8 (22.2) | 11 (30.6) | 0.59 b |
 No | 28 (77.8) | 25 (69.4) | |
Name of the analgesic used | |||
 Piroxicam | 2 (5.6) | 3 (8.3) | 0.90 c |
 Celecoxib | 2 (5.6) | 5 (13.9) | |
 Gabapentin | 3 (8.3) | 2 (5.6) | |
 Naproxen | 1 (2.8) | 1 (2.8) | |
Use of hypnotics | |||
 Yes | 14 (38.9) | 6 (16.7) | 0.06 b |
 No | 22 (61.1) | 30 (83.3) | |
Name of the hypnotic used | |||
 Clonazepam | 6 (16.7) | 3 (8.3) | .99 c |
 Alprazolam | 8 (22.2) | 3 (8.3) | |